Kraig Biocraft Laboratories, a global leader in spider silk technology, has received its official business license to begin operations in Cambodia. The move marks a strategic milestone in the company’s plan to expand and diversify production following the strong momentum gained from its 2025 expansion efforts.

The decision to establish a presence in Cambodia aligns with Kraig Labs commitment to scaling its proprietary recombinant spider silk materials. The Southeast Asian country offers favorable climate conditions, developing infrastructure, and an enabling environment to support industrial biotechnology.

“This license represents more than just geographic growth it’s a reflection of the strong foundation we’ve built through our 2025 production expansion,” said Jon Rice, COO of Kraig Labs. “Cambodia offers the right combination of climate, infrastructure, and opportunity to support the next phase of our spider silk production scale up.”

Kraig Labs expects the Cambodian operations to boost overall production capacity while also reducing risks through geographical diversification. The company will continue to invest in both research and infrastructure to enhance the scalability and performance of its eco-friendly biomaterials.

The expansion supports Kraig Labs broader goal of establishing a robust global production network to support commercial roll-out. The company has pioneered advancements in spider silk applications, known for their strength and flexibility, with potential use in defense, textiles, and medical sectors.

With this new foothold in Cambodia, Kraig Labs reinforces its mission to deliver next-generation biomaterials at scale while supporting sustainable and innovative production platforms.